INMED PHARMACEUTICALS INC. Operating Lease, Lease Income, Lease Payments
INMED PHARMACEUTICALS INC. (INM) reported Operating Lease, Lease Income, Lease Payments of $79.90 thousand for the 6-month period ending 2021-12-31, per its 10-Q filed 2022-02-14.
Discontinued › Income Statement › Other Income
us-gaap:OperatingLeaseLeaseIncomeLeasePayments · last filed 2022-02-14
- 2021-12-31: Operating Lease, Lease Income, Lease Payments 6 month $79.90K.
| Period end | Operating Lease, Lease Income, Lease Payments 6 month |
|---|---|
| 2021-12-31 | $79.90K 10-Q · filed 2022-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |